
PMC:7200337 / 111793-112005
Annnotations
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32505227-29242543-46575472 | 206-210 | 29242543 | denotes | 2018 |
T10568 | 206-210 | 29242543 | denotes | 2018 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T60 | 30-34 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T128 | 206-210 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 162-167 | http://purl.obolibrary.org/obo/GO_0007568 | denotes | aging |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3649 | 51-53 | Gene | denotes | to | Gene:6999 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T666 | 0-212 | Sentence | denotes | In conjunction with the large body of work related to immune senescence, these findings indicate that vaccine design should take into consideration the impact of aging on vaccine efficacy (Nikolich-Žugich, 2018). |